APA (7th ed.) Citation

Bo Ding & Yanming Lu. (2024). Omalizumab in combination with subcutaneous immunotherapy for the treatment of multiple allergies associated with attention-deficit/hyperactivity disorder: A case report and a literature review. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Bo Ding and Yanming Lu. Omalizumab in Combination with Subcutaneous Immunotherapy for the Treatment of Multiple Allergies Associated with Attention-deficit/hyperactivity Disorder: A Case Report and a Literature Review. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Bo Ding and Yanming Lu. Omalizumab in Combination with Subcutaneous Immunotherapy for the Treatment of Multiple Allergies Associated with Attention-deficit/hyperactivity Disorder: A Case Report and a Literature Review. Frontiers Media S.A., 2024.